| Bhavananda T Reddy, MD | |
|
444 W Bourne Cir Ste 200, Farmington, UT 84025 | |
| (801) 776-0174 | |
| (801) 825-3904 |
| Full Name | Bhavananda T Reddy |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 37 Years |
| Location | 444 W Bourne Cir Ste 200, Farmington, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326130758 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 6341978-1205 (Utah) | Secondary |
| 207RI0011X | Internal Medicine - Interventional Cardiology | 59599 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Yavapai Regional Medical Center | Prescott, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cardiojost Inc | 2062429913 | 12 |
News Archive
Over the past three decades, hand surgeon Scott Wolfe has been conducting research to find a better way to repair a common wrist injury that results in pain, disability and progressive arthritis.
Emergent BioSolutions announced today that, after completion of an inter-agency In Process Review, the Biomedical Advanced Research Development Authority (BARDA) of the U.S. Department of Health and Human Services (HHS) has exercised a contract option to further advance the development of PreviThrax (Recombinant Protective Antigen Anthrax Vaccine, Purified), the company's novel rPA anthrax vaccine candidate.
Preterm infants who receive leg movement training display feet-reaching behaviors similar to that of full-term infants, according to a randomized controlled trial reported in the October issue of Physical Therapy (PTJ), the scientific journal of the American Physical Therapy Association (APTA).
QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today a contractual agreement with Patheon to manufacture clinical supplies of QRxPharma's controlled release Dual-Opioid(TM) formulation (MoxDuo(TM)CR). MoxDuo(TM)CR is designed to provide 12 hours of pain relief in patients suffering from moderate to severe chronic pain (including cancer, lower back, osteoarthritis and neuropathic).
› Verified 3 days ago
| Entity Name | Cardiojost Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023122843 PECOS PAC ID: 2062429913 Enrollment ID: O20060317000050 |
News Archive
Over the past three decades, hand surgeon Scott Wolfe has been conducting research to find a better way to repair a common wrist injury that results in pain, disability and progressive arthritis.
Emergent BioSolutions announced today that, after completion of an inter-agency In Process Review, the Biomedical Advanced Research Development Authority (BARDA) of the U.S. Department of Health and Human Services (HHS) has exercised a contract option to further advance the development of PreviThrax (Recombinant Protective Antigen Anthrax Vaccine, Purified), the company's novel rPA anthrax vaccine candidate.
Preterm infants who receive leg movement training display feet-reaching behaviors similar to that of full-term infants, according to a randomized controlled trial reported in the October issue of Physical Therapy (PTJ), the scientific journal of the American Physical Therapy Association (APTA).
QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today a contractual agreement with Patheon to manufacture clinical supplies of QRxPharma's controlled release Dual-Opioid(TM) formulation (MoxDuo(TM)CR). MoxDuo(TM)CR is designed to provide 12 hours of pain relief in patients suffering from moderate to severe chronic pain (including cancer, lower back, osteoarthritis and neuropathic).
› Verified 3 days ago
| Entity Name | Northwest Allied Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003833179 PECOS PAC ID: 7618972514 Enrollment ID: O20060928000110 |
News Archive
Over the past three decades, hand surgeon Scott Wolfe has been conducting research to find a better way to repair a common wrist injury that results in pain, disability and progressive arthritis.
Emergent BioSolutions announced today that, after completion of an inter-agency In Process Review, the Biomedical Advanced Research Development Authority (BARDA) of the U.S. Department of Health and Human Services (HHS) has exercised a contract option to further advance the development of PreviThrax (Recombinant Protective Antigen Anthrax Vaccine, Purified), the company's novel rPA anthrax vaccine candidate.
Preterm infants who receive leg movement training display feet-reaching behaviors similar to that of full-term infants, according to a randomized controlled trial reported in the October issue of Physical Therapy (PTJ), the scientific journal of the American Physical Therapy Association (APTA).
QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today a contractual agreement with Patheon to manufacture clinical supplies of QRxPharma's controlled release Dual-Opioid(TM) formulation (MoxDuo(TM)CR). MoxDuo(TM)CR is designed to provide 12 hours of pain relief in patients suffering from moderate to severe chronic pain (including cancer, lower back, osteoarthritis and neuropathic).
› Verified 3 days ago
| Entity Name | Northwest Cardiology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154642056 PECOS PAC ID: 6608991526 Enrollment ID: O20100916000024 |
News Archive
Over the past three decades, hand surgeon Scott Wolfe has been conducting research to find a better way to repair a common wrist injury that results in pain, disability and progressive arthritis.
Emergent BioSolutions announced today that, after completion of an inter-agency In Process Review, the Biomedical Advanced Research Development Authority (BARDA) of the U.S. Department of Health and Human Services (HHS) has exercised a contract option to further advance the development of PreviThrax (Recombinant Protective Antigen Anthrax Vaccine, Purified), the company's novel rPA anthrax vaccine candidate.
Preterm infants who receive leg movement training display feet-reaching behaviors similar to that of full-term infants, according to a randomized controlled trial reported in the October issue of Physical Therapy (PTJ), the scientific journal of the American Physical Therapy Association (APTA).
QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today a contractual agreement with Patheon to manufacture clinical supplies of QRxPharma's controlled release Dual-Opioid(TM) formulation (MoxDuo(TM)CR). MoxDuo(TM)CR is designed to provide 12 hours of pain relief in patients suffering from moderate to severe chronic pain (including cancer, lower back, osteoarthritis and neuropathic).
› Verified 3 days ago
| Entity Name | Southwest Cardiovascular Interventional Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1588203723 PECOS PAC ID: 8224458443 Enrollment ID: O20201008003040 |
News Archive
Over the past three decades, hand surgeon Scott Wolfe has been conducting research to find a better way to repair a common wrist injury that results in pain, disability and progressive arthritis.
Emergent BioSolutions announced today that, after completion of an inter-agency In Process Review, the Biomedical Advanced Research Development Authority (BARDA) of the U.S. Department of Health and Human Services (HHS) has exercised a contract option to further advance the development of PreviThrax (Recombinant Protective Antigen Anthrax Vaccine, Purified), the company's novel rPA anthrax vaccine candidate.
Preterm infants who receive leg movement training display feet-reaching behaviors similar to that of full-term infants, according to a randomized controlled trial reported in the October issue of Physical Therapy (PTJ), the scientific journal of the American Physical Therapy Association (APTA).
QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today a contractual agreement with Patheon to manufacture clinical supplies of QRxPharma's controlled release Dual-Opioid(TM) formulation (MoxDuo(TM)CR). MoxDuo(TM)CR is designed to provide 12 hours of pain relief in patients suffering from moderate to severe chronic pain (including cancer, lower back, osteoarthritis and neuropathic).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bhavananda T Reddy, MD 444 W Bourne Cir Ste 200, Farmington, UT 84025-3657 Ph: (801) 397-3000 | Bhavananda T Reddy, MD 444 W Bourne Cir Ste 200, Farmington, UT 84025 Ph: (801) 776-0174 |
News Archive
Over the past three decades, hand surgeon Scott Wolfe has been conducting research to find a better way to repair a common wrist injury that results in pain, disability and progressive arthritis.
Emergent BioSolutions announced today that, after completion of an inter-agency In Process Review, the Biomedical Advanced Research Development Authority (BARDA) of the U.S. Department of Health and Human Services (HHS) has exercised a contract option to further advance the development of PreviThrax (Recombinant Protective Antigen Anthrax Vaccine, Purified), the company's novel rPA anthrax vaccine candidate.
Preterm infants who receive leg movement training display feet-reaching behaviors similar to that of full-term infants, according to a randomized controlled trial reported in the October issue of Physical Therapy (PTJ), the scientific journal of the American Physical Therapy Association (APTA).
QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today a contractual agreement with Patheon to manufacture clinical supplies of QRxPharma's controlled release Dual-Opioid(TM) formulation (MoxDuo(TM)CR). MoxDuo(TM)CR is designed to provide 12 hours of pain relief in patients suffering from moderate to severe chronic pain (including cancer, lower back, osteoarthritis and neuropathic).
› Verified 3 days ago
Stephanie L Olsen, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 444 W Bourne Cir Ste 200, Farmington, UT 84025 Phone: 801-776-0174 Fax: 801-825-3904 | |
Dr. Roja R Mulamalla, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 444 W Bourne Cir Ste 200, Farmington, UT 84025 Phone: 801-776-0174 Fax: 801-825-3904 | |
Christopher Y Kim, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 444 W Bourne Cir Ste 200, Farmington, UT 84025 Phone: 801-776-0176 Fax: 801-825-3904 | |
Chad B Mcbride, D.O Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 444 W Bourne Cir Ste 200, Farmington, UT 84025 Phone: 801-776-0174 Fax: 801-825-3904 | |
Daniel J Humiston, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 444 W Bourne Cir Ste 200, Farmington, UT 84025 Phone: 801-776-0174 Fax: 801-825-3904 | |
Sandeep Talwar, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 444 W Bourne Cir Ste 200, Farmington, UT 84025 Phone: 801-776-0174 Fax: 801-825-3904 |